Brief: Adial Pharmaceuticals Announces Reverse Stock Split
04/08/2023 13:35
Aug 4 (Reuters) - Adial Pharmaceuticals Inc ADIL.O :
* ADIAL PHARMACEUTICALS ANNOUNCES REVERSE STOCK SPLIT TO
REGAIN
COMPLIANCE WITH NASDAQ’S MINIMUM BID PRICE REQUIREMENT AND
REDUCE THE PUBLIC FLOAT
* ADIAL PHARMACEUTICALS INC ANNOUNCES 1 FOR 25 REVERSE STOCK
SPLIT
* ADIAL PHARMACEUTICALS INC - WILL EFFECT A 1-FOR-25 REVERSE
STOCK
SPLIT OF ITS COMMON STOCK THAT WILL BECOME EFFECTIVE ON AUGUST 4
Source text for Eikon: ID:nGNXch8SpV
Further company coverage: ADIL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adial Pharmaceuticals
See all newsBrief: Adial Pharmaceuticals Announces Name Change To Azora Therapeutics
Brief: Adial Pharmaceuticals Announces Planned Appointment Of Celia Economides As Chief Financial Officer
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Adial Pharmaceuticals - Proposed Resale Of Up To 25,148,970 Shares Of Common Stock By Selling Stockholders - SEC Filing
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)